IDiyas

For the Inventor, By the Inventor

Waltham, MA, United States of America

Christopher Young

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 3.4

ph-index = 15

Forward Citations = 905(Granted Patents)


Location History:

  • Mashpee, MA (US) (2005)
  • Sudbury, MA (US) (2015)
  • Waltham, MA (US) (2009 - 2023)

Company Filing History:

goldMedal18 out of 1,149 
 
Vertex Pharmaceuticals, Inc.
 patents
silverMedal1 out of 1 
 
Intelligent Meetings Corp.
 patent

Years Active: 2005-2025

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):
1. 12458635 - Pharmaceutical composition and administrations thereof (2025-11-04),
2. 11564916 - Pharmaceutical composition and administrations thereof (2023-01-31),
3. 11291662 - Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2022-04-05),
4. 11052075 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof (2021-07-06),
5. 10646481 - Pharmaceutical composition and administrations thereof (2020-05-12),
6. 10537565 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2020-01-21),
7. 10076513 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof (2018-09-18),
8. 9931334 - Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2018-04-03),
9. 9670163 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2017-06-06),
10. 9241934 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof (2016-01-26),
11. 9192606 - Dosage units of 3-(6-(1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (2015-11-24),
12. 9139530 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2015-09-22),
13. 8754224 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2014-06-17),
14. 8716338 - Dosage units of 3-(6-(1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (2014-05-06),
15. 8552034 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof (2013-10-08),

Certainly! Here is the article about inventor Christopher Young:

Title: Innovator Spotlight: Christopher Young - Pioneering Pharmaceutical Solutions in Waltham, MA

Introduction: Christopher Young, a distinguished inventor based in Waltham, MA, is renowned for his groundbreaking work in the field of pharmaceutical compositions. With an impressive track record of 17 patents to his name, Young continues to revolutionize the industry with his innovative solutions.

Latest Patents: Among his recent achievements are patents for "Pharmaceutical composition and administrations thereof" and "Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide". These inventions highlight his expertise in developing novel pharmaceutical formulations and methods of administration, pushing the boundaries of medical science.

Career Highlights: Christopher Young is a key member of the research and development team at Vertex Pharmaceuticals, Inc. His contributions have not only propelled the company's success but have also benefited the broader pharmaceutical community. Young's keen insights and dedication have made him a leading figure in the industry.

Collaborations: In his collaborative efforts, Christopher Young has worked closely with esteemed colleagues such as Patricia Nell Hurter and William Rowe. Together, they have synergized their expertise to drive innovation, resulting in impactful solutions that have reshaped the landscape of pharmaceuticals.

Conclusion: Christopher Young's unwavering commitment to advancing pharmaceutical research and development underscores his significance as a visionary inventor. With a strong foundation of patents and a spirit of collaboration, Young continues to inspire change and shape the future of medicine.

Thank you for providing the information about this outstanding innovator! If you have any more requests or need further assistance, feel free to let me know.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…